Skip to main content
All lobbying clients

Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc. has lobbied on its own behalf and been represented by 4 lobbying firms in 25 filings since 2025, with $2,480,000 in reported spending; the newest was posted October 20, 2026.

As filed: MADRIGAL PHARMACEUTICALS, INC. Client based in Pennsylvania.

Biopharmaceutical company.

$2,480,000 Reported spend
25 Filings counted
4 Outside firms hired
0 Bills named

Spend is reported income plus in-house expenses across 25 filings. 1 further filing for this client was restated by a later amendment and is left out of every total here. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 5 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as MADRIGAL PHARMACEUTICALS.

 Who filed for this client 5

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Reported by year 2 years
  • 2026 $1,800,000 13 filings
  • 2025 $680,000 12 filings
 Issues lobbied 9

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 4
  • HOUSE OF REPRESENTATIVES 13
  • SENATE 13
  • Health & Human Services, Dept of (HHS) 3
  • U.S. Trade Representative (USTR) 2
 Recent filings 26 total
Q3 report
Capitol Counsel LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View → Q3 report
Madrigal Pharmaceuticals, Inc.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $350,000 expenses · posted Oct 19, 2026
View → Q3 report
Crossroads Strategies, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 19, 2026
View → Q3 report
Ballard Partners
3rd Quarter 2026 (July 1 - Sep 30) · $120,000 income · posted Oct 18, 2026
View → Q2 report
Madrigal Pharmaceuticals, Inc.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $380,000 expenses · posted Jul 20, 2026
View → Q2 report
Crossroads Strategies, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 19, 2026
View → Q2 report
Capitol Counsel LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 16, 2026
View → Q2 report
Ballard Partners
2nd Quarter 2026 (Apr 1 - June 30) · $120,000 income · posted Jul 15, 2026
View → Q1 report
Madrigal Pharmaceuticals, Inc.
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $380,000 expenses · posted Apr 24, 2026
View → Q1 report
Crossroads Strategies, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $50,000 income · posted Apr 20, 2026
View → Q1 report
Capitol Counsel LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $60,000 income · posted Apr 18, 2026
View → Q1 report
Ballard Partners
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $120,000 income · posted Apr 16, 2026
View → Registration
Capitol Counsel LLC
1st Quarter 2026 (Jan 1 - Mar 31) · posted Feb 18, 2026
View → Q4 report
Madrigal Pharmaceuticals, Inc.
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $280,000 expenses · posted Jan 22, 2026
View → Q4 report
Crossroads Strategies, LLC
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $50,000 income · posted Jan 20, 2026
View → Q4 termination
Thorn Run Partners
4th Quarter 2025 (Oct 1 - Dec 31) · $40,000 income · posted Jan 19, 2026
View → Q4 amendmentNo activity
Ballard Partners
4th Quarter 2025 (Oct 1 - Dec 31) · $80,000 income · posted Jan 14, 2026
View → Q4 reportNo activity
Ballard Partners Amended
4th Quarter 2025 (Oct 1 - Dec 31) · $60,000 income · posted Jan 14, 2026
View → Registration
Ballard Partners
4th Quarter 2025 (Oct 1 - Dec 31) · posted Dec 9, 2025
View → Q3 amendment
Madrigal Pharmaceuticals, Inc.
3rd Quarter 2025 (July 1 - Sep 30) · $30,000 expenses · posted Dec 4, 2025
View →

Showing the 20 most recent of 26 filings. Search the explorer for "MADRIGAL PHARMACEUTICALS, INC.".

Keep going

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem